Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

SunMax Biotechnology Co. Ltd. (4728) Financial Statements

SunMax Biotechnology Co. Ltd. Financial Overview

SunMax Biotechnology Co. Ltd.'s market cap is currently NT$21.13B. The company's EPS TTM is NT$14.90; its P/E ratio is 26.04; and it has a dividend yield of 6.11%. SunMax Biotechnology Co. Ltd. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueNT$ 2.03BNT$ 1.82BNT$ 1.69BNT$ 1.40BNT$ 1.04B
Gross ProfitNT$ 1.59BNT$ 735.15MNT$ 1.40BNT$ 1.19BNT$ 894.45M
Operating IncomeNT$ 998.31MNT$ 926.96MNT$ 894.79MNT$ 777.68MNT$ 362.63M
EBITDANT$ 1.10BNT$ 911.19MNT$ 985.16MNT$ 836.35MNT$ 415.70M
Net IncomeNT$ 725.75MNT$ 679.40MNT$ 625.71MNT$ 533.83MNT$ 245.64M
Balance Sheet
Cash & Short-Term InvestmentsNT$ 961.59MNT$ 333.22MNT$ 961.79MNT$ 816.67MNT$ 679.34M
Total AssetsNT$ 2.12BNT$ 1.85BNT$ 2.16BNT$ 1.79BNT$ 1.48B
Total DebtNT$ 119.33MNT$ 60.34MNT$ 169.02MNT$ 70.33MNT$ 109.06M
Net DebtNT$ -592.26MNT$ -182.89MNT$ -685.68MNT$ -518.97MNT$ -493.49M
Total LiabilitiesNT$ 505.60MNT$ 337.82MNT$ 732.99MNT$ 468.00MNT$ 460.44M
Stockholders' EquityNT$ 1.62BNT$ 1.51BNT$ 1.43BNT$ 1.33BNT$ 1.02B
Cash Flow
Free Cash FlowNT$ 757.58MNT$ 360.75MNT$ 738.16MNT$ 489.40MNT$ -12.14M
Operating Cash FlowNT$ 825.92MNT$ 397.37MNT$ 848.56MNT$ 644.57MNT$ 243.28M
Investing Cash FlowNT$ -239.96MNT$ 308.86MNT$ -16.04MNT$ -376.62MNT$ -285.17M
Financing Cash FlowNT$ -663.13MNT$ -604.92MNT$ -549.80MNT$ -281.21MNT$ -131.97M

Currency in TWD

SunMax Biotechnology Co. Ltd. Earnings and Revenue History

0800M1.6B2.4B10 %20 %30 %40 %EarningsProfit Margin2019202020212022202320242025RevenueEarningsProfit Margin
Income Statement >

SunMax Biotechnology Co. Ltd. Liabilities to Assets

0800M1.6B2.4B12 %24 %36 %48 %LiabilitiesLiabilities to Assets2019202020212022202320242025AssetsLiabilitiesLiabilities to Assets
Balance Sheet >

SunMax Biotechnology Co. Ltd. Cash Flow

-1B-500M0500M1B2019202020212022202320242025OperatingInvestingFinancing
Cash Flow >

SunMax Biotechnology Co. Ltd. Forecast EPS vs Actual EPS

2.52.833.33.53.844.34.5Q1 25Q2 25Q3 25Q4 25Q1 26Q3 26EPS EstimateBeatMiss
Earnings >